http://www.acc.org/Feed?clinicalTopicID=2e96633a-1c99-4f33-9eda-83554d60f058 Clinical Topic Feed: Interventions and Coronary Artery Disease en /Latest-in-Cardiology/Articles/2026/07/29/13/18/eagles-eye-view-29jul2026 In this week’s View, Dr. Eagle looks at a post-hoc analysis of the API-CAT trial that showed recurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival of patients with cancer-associated thrombosis. 1785331140000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/07/22/17/25/DAPT-MVD Extending DAPT for an additional year reduced major adverse cardiovascular events (MACE) without increasing bleeding risk compared with aspirin alone among patients with multivessel coronary artery disease (MVCAD) who had no ischemic or bleeding events one year after PCI with a drug-eluting stent, according to results of the DAPT-MVD trial published July 15 in NEJM. 1784749860000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/08/10/20/Optimizing-Dual-Antiplatelet-Therapy The TUXEDO-2 (Ultrathin Strut vs. Xience in a Diabetic Population With Multivessel Disease 2—India Study) trial demonstrated that among patients with diabetes mellitus and multivessel coronary artery disease undergoing percutaneous coronary intervention (PCI)... 1781024040000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1780315620000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/05/04/11/24/ORBITA-Analysis Patients with lower microvascular resistance (MVR) saw greater placebo-controlled benefit from PCI, according to a retrospective analysis of the ORBITA trial published April 29 in JACC: Cardiovascular Interventions. 1778087340000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/27/19/07/ACC26-Coronary-Interventional-Trials Late-breaking clinical trials presented at ACC.26 focusing on coronary interventions included several looking at intravascular guidance in complex, high-risk procedures (IVUS-CHIP), bifurcation lesions (DKCRUSH VIII), and unprotected left main PCI (OPTIMAL). 1777570260000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/04/28/20/06/noble No significant difference was observed in all-cause mortality at 10 years between PCI and CABG in patients with unprotected left main coronary artery disease (CAD) and no additional complex lesions, according to the final results of the NOBLE study published April 4 in The Lancet. 1777412340000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/21/15/23/ACC26-Structural-Intervention-Trials-Offer-Viable-Options Late-breaking clinical trials presented at ACC.26 focusing on structural interventions included the PROTECT H2H trial comparing two embolic protection devices (EPDs) in patients undergoing transcatheter aortic valve implantation (TAVI), the PRO-TAVI trial comparing a strategy of routine PCI with a deferred approach... 1776939000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-protavi-acc-2026 Older patients with coronary artery disease (CAD) for whom PCI was deferred until after TAVI had similar outcomes as those for whom it was not deferred, according to findings from the PRO-TAVI study presented in a Late-Breaking Clinical Trial session... 1774818600000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/18/00/50/eagles-eye-view-18mar2025 In this week’s View, Dr. Eagle looks at data from the STS/ACC TVT Registry on off label transcatheter valve interventions that demonstrate reduced residual tricuspid regurgitation (TR) and improved quality of life. 1773842400000 Articles and Stories